Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Plummer

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT studyJ T Lear, M R Migden, K D Lewis, et al.
Nature Communications|June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Nature Communications|January 17, 2023
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2022
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022D Araujo, A Greystoke, S Bates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJ C Soria, H K Gan, S P Blagden, et al.
European Radiology|May 8, 2012
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imagingM O Leach, B Morgan, P S Tofts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Physical Review Letters|August 26, 2022
Lawson Criterion for Ignition Exceeded in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Physical Review Letters|February 23, 2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT studyJ T Lear, M R Migden, K D Lewis, et al.
Nature Communications|June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Nature Communications|January 17, 2023
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2022
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022D Araujo, A Greystoke, S Bates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJ C Soria, H K Gan, S P Blagden, et al.
European Radiology|May 8, 2012
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imagingM O Leach, B Morgan, P S Tofts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Physical Review Letters|August 26, 2022
Lawson Criterion for Ignition Exceeded in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Physical Review Letters|February 23, 2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion ExperimentH Abu-Shawareb, R Acree, P Adams, et al.
Pageof 15